Description

+ Include: 7 videos + 38 pdfs, size: 2.21 GB

+ Target Audience: cardiologists, internists, primary care physicians

+ Sample video: contact me for sample video

+ Information:

This course provides comprehensive training for healthcare professionals in the advanced management of heart failure. The curriculum is designed to equip participants with the latest knowledge and skills necessary to optimize patient outcomes through innovative therapeutic strategies and interventions.

After completing this course, participants will be able to

• Apply appropriate strategies to optimize use of current and novel drug therapy of heart failure with reduced left ventricular ejection fraction
• Describe how to utilize medical devices and surgical therapies in the care of heart failure patients
• Discuss the clinical profile of heart failure and differentiate between reduced and preserved ejection fraction patients
• Discuss the latest findings concerning pharmacological approaches to heart failure with midrange or preserved ejection fraction
• Employ current therapeutic strategies for cardiac amyloid and hypertrophic cardiomyopathy
• Identify options for electrophysiological interventions to address risk of sudden death and atrial arrhythmias in patients with heart failure

Who Should Attend?

The course is directed to physicians, physician assistants, pharmacists, nurse practitioners, nurses, and all healthcare providers with an interest in treating and managing patients with heart failure.

 

+ Topics:

Agenda.pdf

June 6 Advanced evaluation of the breathless patient.pdf

June 6 AF ablation and the pulsed field era.pdf

June 6 Arrhythmogenic cardiomyopathies and genetic testing.pdf

June 6 Breakthroughs in obesity-related HFpEF.pdf

June 6 Cardiac contractility modulation.pdf

June 6 Current and emerging device-based therapies for HFpEF.pdf

June 6 Educating and engaging the patient of tomorrow.pdf

June 6 GDMT optimization across the inpatient-outpatient domain.pdf

June 6 Harnessing tech for GDMT optimization and readmission reduction.pdf

June 6 Harnessing the heart team for GDMT equity.pdf

June 6 HF STATS The changing face of heart failure.pdf

June 6 Lessons learnt for diverse HF trial recruitment.pdf

June 6 New insights into HFpEF mechanisms.pdf

June 6 Novel therapies for cardiomyopathies.pdf

June 6 Remote monitoring in the “AI era”- Leveraging new devices and algorithms.pdf

June 6 Remote monitoring the “old school” way- Weights, vitals and symptoms.pdf

June 6 Session 1 – Updates in HF Epidemiology and Population Health.mp4

June 6 Session 2 – HFrEF and EP Innovations.mp4

June 6 Session 3 – HFpEF and Pulmonary Hypertension.mp4

June 6 Session 4A – Meet the Clinical Trialists (Concurrent Session).mp4

June 6 The future of remote HF and EP monitoring.pdf

June 6 The LAA and controversies in anticoagulation.pdf

June 6 The next frontier- earlier diagnosis and treatment of HF.pdf

June 6 The next generation HFrEF therapies.pdf

June 6 Trials and tribulations in valvular interventions.pdf

June 6 Ventricular tachycardia in patients with HFrEF.pdf

June 6 What’s new in pulmonary hypertension.pdf

June 7 A positive PET scan- What comes next.pdf

June 7 Collapse to comeback- Improving outcomes after cardiac arrest.pdf

June 7 DanGer ahead- Seeking an evidence base for shock management.pdf

June 7 Evolutions in organ preservation and transportation.pdf

June 7 Fixing the flow- Revascularization for the high-risk patient.pdf

June 7 Getting shock right- Managing the right ventricle.pdf

June 7 HCM in the era of myosin inhibition.pdf

June 7 LVADs in a Transplant World.pdf

June 7 Managing MCS at a non-transplant center.pdf

June 7 Managing TTR cardiac amyloidosis in 2025.pdf

June 7 Multidisciplinary cardiac care during pregnancy.pdf

June 7 Post-heart transplant outcomes and management innovations.pdf

June 7 Session 1 – Cardiomyopathies (amyloid, HCM, Sarcoid) and HFrEF.mp4

June 7 Session 2 – MCS and TX.mp4

June 7 Session 3 – Cardiogenic shock and critical care.mp4

June 7 The next generation of LVADs and trials.pdf

June 7 Transplant and VAD options in congenital conditions.pdf